Company: ARWR
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001628280-25-038858
Chunk: 107

Company: ARROWHEAD PHARMACEUTICALS, INC.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 8
Chunk 107
---
 to an increase in headcount. Stock compensation decreased $0.7 million, or 3%, for the nine months ended June 30, 2025 compared to the same period of 2024, primarily due to the cancellation of awards upon the departure of employees.

Depreciation and amortization expense, a non-cash expense, relates to depreciation on buildings, lab equipment and leasehold improvements. These expenses increased $1.4 million, or 34% for the three months ended June 30, 2025 and $3.8 million, or 31%, for the nine months ended June 30, 2025 compared to the same periods of 2024. The increase was primarily attributable to completion of the build out of facilities in Verona, Wisconsin, and the commencement of depreciation.

General & Administrative Expenses 

The following tables provide details of general and administrative expenses for the periods indicated: (in thousands)Three Months Ended June 30, 2025% ofExpenseCategory Three Months Ended June 30, 2024% ofExpenseCategory Increase (Decrease)$% Salaries$7,964 26 %$6,740 28 %$1,224 18 %Professional, outside services, and other 14,869 47 %5,410 24 %9,459 175 %Facilities related2,180 7 %1,238 5 %942 76 %Total general & administrative expense, excluding non-cash expenses$25,013 80 %$13,388 57 %$11,625 87 %Stock compensation5,431 18 %9,809 41 %(4,378)(45)%Depreciation and amortization505 2 %513 2 %(8)(2)%Total general & administrative expenses$30,949 100 %$23,710 100 %$7,239 31 %

(in thousands)Nine Months Ended June 30, 2025% ofExpenseCategory Nine Months Ended June 30, 2024% ofExpenseCategory Increase (Decrease)$% Salaries$23,152 27 %$20,087 28 %$3,065 15 %Professional, outside services, and other35,811 41 %16,910 23 %18,901 112 %Facilities related4,546 5 %3,278 5